Hodgkin Lymphoma — Trials

Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

972 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 179
Recruiting: 90
Ph III recruiting: 6
Growth YoY: −4.2%
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%
Trials / 1,000 deaths: 175.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 1–50 of 56 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06377540	MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma	recruiting	Phase 2	28	Masonic Cancer Center, University of MinnesotaOTHER	1	Sep 29, 2026	clinicaltrials
NCT03418038	Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia	recruiting	Phase 2	80	Mayo ClinicOTHER	1	Sep 28, 2026	clinicaltrials